Tuesday, 31 Mar 2020

You are here

RheumNow Week in Review - 3 June 2016

This week's highlights from RheumNow.com include:

  1. In a study of knee OA patients they examined the frequency of venous thrombotic events (VTE) (n=4020) and compared with controls having VTE(1:5). NSAID use (diclofenac, meloxicam, ibuprofen, coxibs; but not naproxen) was associated with a ~40% increase VTE risk.  https://t.co/itQexYqRk8
  2. Myositis experts consensus says that after steroids, azathioprine, methotrexate and mycophenolate are most commonly chosen agents to manage myositis. https://t.co/wboHZ7dJQe
  3. FDA rules to lower salt content by manufacturers & restaurants – recommending a decrease in daily salt  intake from 3.4 to 2.3 g/day. https://t.co/wJC7G5DNZS 
  4. 1487 patients with low back pain were reviewed for their medication use. Low rates of med use found: only 18.7% taking meds for back pain; anxiolytics 14%; NSAIDs 12%; analgesic 7%; muscle relaxants 3%; opioids 1.6%. https://t.co/oJH6DCWP0D
  5. Recurrent acute anterior uveitis responds to golimumab 50 mg qmo; 12/15 eyes from B27+ AS patients improve, going into remission https://t.co/0ttwTe56zv
  6. Samsung Bioepis has a new biosimilar “Flixabi” (a Remicade biosimilar) approved for all 6 indications in 28 EU states & Norway, Iceland. https://t.co/oHwkbozHSG
  7. Morning Stiffness Madness - Dr. Cush debunks the importance of morning stiffness as an inflammatory indicator. 
  8. Patient Reluctance to Take Bisphosphonates
  9. Lower GI Perforation Risk Noted for Tofacitinib and Tocilizumab
Disclosures: 
The author has received research/grant financial support on this subject
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

TeleRheumatology - a TED Talk by Alvin Wells, MD

RheumNow Live 2020 featured a series of shorter STEP (TED-like) talks. This one features Dr. Alvin Wells discussing the opportunities and new paradigms encumbent with telemedicine in rheumatology.

RheumNow Podcast – New World Order (3.27.20)

Dr. Jack Cush reviews the news and COVID developments from this past week.

Global Rheumatology Alliance Registry Will Study COVID-19

In the midst of a global pandemic of the 2019 Novel coronavirus acute respiratory disease (COVID-19), a small handful of Rheumatologists gathered on social media to collectively grapple with the impact of this virus on vulnerable populations with rheumatic disease.

RheumNow Podcast- COVID Siege (3.20.20)

Dr. Jack Cush reviews the past week of COVID-19 news and advances.

COVID-19 Rheumatology News

With the COVID-19 pandemic dynamically changing, we have provided several news items germane to the Rheumatologist.